These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Numbers of mutations to different types of colorectal cancer. Calabrese P; Mecklin JP; Järvinen HJ; Aaltonen LA; Tavaré S; Shibata D BMC Cancer; 2005 Oct; 5():126. PubMed ID: 16202134 [TBL] [Abstract][Full Text] [Related]
50. MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways. Liu X; Wang Y; Zhao J Oncol Rep; 2017 Nov; 38(5):3187-3196. PubMed ID: 29048669 [TBL] [Abstract][Full Text] [Related]
51. Identification of constrained cancer driver genes based on mutation timing. Sakoparnig T; Fried P; Beerenwinkel N PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148 [TBL] [Abstract][Full Text] [Related]
52. Identifying restrictions in the order of accumulation of mutations during tumor progression: effects of passengers, evolutionary models, and sampling. Diaz-Uriarte R BMC Bioinformatics; 2015 Feb; 16():41. PubMed ID: 25879190 [TBL] [Abstract][Full Text] [Related]
54. A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer. Saito T; Niida A; Uchi R; Hirata H; Komatsu H; Sakimura S; Hayashi S; Nambara S; Kuroda Y; Ito S; Eguchi H; Masuda T; Sugimachi K; Tobo T; Nishida H; Daa T; Chiba K; Shiraishi Y; Yoshizato T; Kodama M; Okimoto T; Mizukami K; Ogawa R; Okamoto K; Shuto M; Fukuda K; Matsui Y; Shimamura T; Hasegawa T; Doki Y; Nagayama S; Yamada K; Kato M; Shibata T; Mori M; Aburatani H; Murakami K; Suzuki Y; Ogawa S; Miyano S; Mimori K Nat Commun; 2018 Jul; 9(1):2884. PubMed ID: 30038269 [TBL] [Abstract][Full Text] [Related]
55. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression. Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630 [TBL] [Abstract][Full Text] [Related]
56. Establishment and characterization of cell lines from chromosomal instable colorectal cancer. Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089 [TBL] [Abstract][Full Text] [Related]
57. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan. Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582 [TBL] [Abstract][Full Text] [Related]
58. Discovery of co-occurring driver pathways in cancer. Zhang J; Wu LY; Zhang XS; Zhang S BMC Bioinformatics; 2014 Aug; 15(1):271. PubMed ID: 25106096 [TBL] [Abstract][Full Text] [Related]
59. Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Lannagan TRM; Lee YK; Wang T; Roper J; Bettington ML; Fennell L; Vrbanac L; Jonavicius L; Somashekar R; Gieniec K; Yang M; Ng JQ; Suzuki N; Ichinose M; Wright JA; Kobayashi H; Putoczki TL; Hayakawa Y; Leedham SJ; Abud HE; Yilmaz ÖH; Marker J; Klebe S; Wirapati P; Mukherjee S; Tejpar S; Leggett BA; Whitehall VLJ; Worthley DL; Woods SL Gut; 2019 Apr; 68(4):684-692. PubMed ID: 29666172 [TBL] [Abstract][Full Text] [Related]
60. Accurate reconstruction of the temporal order of mutations in neoplastic progression. Sprouffske K; Pepper JW; Maley CC Cancer Prev Res (Phila); 2011 Jul; 4(7):1135-44. PubMed ID: 21490131 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]